1. Home
  2. ALMS vs LZM Comparison

ALMS vs LZM Comparison

Compare ALMS & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • LZM
  • Stock Information
  • Founded
  • ALMS 2021
  • LZM 2021
  • Country
  • ALMS United States
  • LZM Isle of Man
  • Employees
  • ALMS N/A
  • LZM N/A
  • Industry
  • ALMS
  • LZM Metal Mining
  • Sector
  • ALMS
  • LZM Basic Materials
  • Exchange
  • ALMS NYSE
  • LZM Nasdaq
  • Market Cap
  • ALMS 469.0M
  • LZM 483.7M
  • IPO Year
  • ALMS 2024
  • LZM N/A
  • Fundamental
  • Price
  • ALMS $5.17
  • LZM $5.40
  • Analyst Decision
  • ALMS Strong Buy
  • LZM Strong Buy
  • Analyst Count
  • ALMS 7
  • LZM 2
  • Target Price
  • ALMS $28.83
  • LZM $12.50
  • AVG Volume (30 Days)
  • ALMS 263.6K
  • LZM 73.9K
  • Earning Date
  • ALMS 02-28-2025
  • LZM 03-31-2025
  • Dividend Yield
  • ALMS N/A
  • LZM N/A
  • EPS Growth
  • ALMS N/A
  • LZM N/A
  • EPS
  • ALMS N/A
  • LZM N/A
  • Revenue
  • ALMS N/A
  • LZM $1,020,728.00
  • Revenue This Year
  • ALMS N/A
  • LZM N/A
  • Revenue Next Year
  • ALMS N/A
  • LZM $890.00
  • P/E Ratio
  • ALMS N/A
  • LZM N/A
  • Revenue Growth
  • ALMS N/A
  • LZM N/A
  • 52 Week Low
  • ALMS $4.74
  • LZM $4.61
  • 52 Week High
  • ALMS $13.53
  • LZM $9.51
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • LZM 30.34
  • Support Level
  • ALMS N/A
  • LZM $5.62
  • Resistance Level
  • ALMS N/A
  • LZM $6.13
  • Average True Range (ATR)
  • ALMS 0.00
  • LZM 0.28
  • MACD
  • ALMS 0.00
  • LZM -0.03
  • Stochastic Oscillator
  • ALMS 0.00
  • LZM 4.84

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises two segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary.

Share on Social Networks: